Vijaya Diagnostic Centre Limited is an India-based company, specialising in providing a range of diagnostic services. These services include pathological investigations, basic and advanced radiology, nuclear medicine and associated healthcare solutions.
The company has 121 facilities spread across 20 cities. Each diagnostic centre is equipped with National Accreditation Board for Testing and Calibration Laboratories (NABL). The workforce comprises over 2,400 professionals, including more than 200 pathologists, radiologists and microbiologists.
With its listing in the BSE and NSE in 2021, Vijaya Diagnostic became the first integrated diagnostic chain in South India to secure listing on both these exchanges.
Vijaya Diagnostic Centre market capitalisation stood at over ₹6,800 crore as of February 27, 2024. Vijaya Dignostic share price has surged over 75% in the past one year.
Vijaya Diagnostic is among the largest integrated diagnostic chain in South India. Founded in 1981 by Dr. S. Surendranath Reddy in Hyderabad, it has been operating diagnostic centre chains in India for over four decades. The business underwent a transition in 2005, moving from a proprietorship to a corporate entity.
Presently, it operates over 145 diagnostic centres nationwide, with 90 centres located solely in Hyderabad, Telangana. Branches can also be found in other parts of Telangana and Andhra Pradesh, including Sangareddy, Warangal, Hanmakonda, Karimnagar, Kurnool, Nizamabad, Wanaparthy, Nellore, Tirupathi, Rajahmundry, and Visakhapatnam.
Outside Andhra Pradesh and Telangana, Vijaya Diagnostic centres are situated in Kolkata and Gurgaon.
Pathology tests from basic biochemistry and clinical pathology to advanced cytogenetics and high-end molecular diagnostic tests are available at Vijaya Diagnostic. Furthermore, it provides radiology testing that ranges from simple X-rays, ultrasounds and echocardiograms to complex imaging methods like advanced positron emission tomography CT (PET CT), single photon emission computed tomography (SPECT), CT scans and computerised tomography (CT) scans.
Vijaya Diagnostic offers more than 2,000 pathology tests and 550 radiology tests. To ensure that patients get their results as soon as possible, the tests are carried out effectively. The NABL has certified each of the labs run by Vijaya Diagnostic.
It provides home sample collection for over 21 medical specialties, bringing its medical diagnostic services directly to the patient’s doorsteps.
Vijaya Diagnostic Centre Limited offers a range of corporate wellness services, including health examinations conducted both on and off site. Its corporate clientele includes more than 400 international companies that do business in India.
It offers a range of health checkup packages, with prices ranging from as low as ₹1,500 to upwards of ₹28,000, depending on the tests. These health checkups are important as they enable people to detect serious health issues early.
– The net revenue in FY23 was ₹459 crore compared to ₹462 crore in the previous fiscal year. – Vijaya Diagnostic’s net profit was ₹84.6 crore in FY23, compared to ₹109.7 crore in FY22. – The company’s EBITDA (earnings before interest tax depreciation and amortisation) stood at ₹182 crore in FY23 as against ₹203.7 crore in FY22. – The EBITDA margin was 39.6% in FY23, compared to 44.1% in FY22. – Vijaya Diagnostic’s earnings per share (EPS) was ₹8.29 in FY23 compared to ₹10.76 in FY22.
As of 26 May 2026, Vijaya Diagnostic Center share price is ₹1,220.40. The stock opened at ₹1,240.00, compared to its previous close of ₹1,227.10. During today's trading session, Vijaya Diagnostic Center share price moved in the range of ₹1,212.00 to ₹1,240.00, with an average price of ₹1,226.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,212.00 and a high of ₹1,240.00. On the performance front, Vijaya Diagnostic Center share price has increased by 21.00% over the last six months and is up 33.96% on a year-on-year basis.
The market capitalization of Vijaya Diagnostic Center is ₹12,604 Crs, with a P/E ratio of 72.9 and a dividend yield of 0.16%.